HUANG Jian | China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Unive
スポンサーリンク
概要
- 同名の論文著者
- China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Univeの論文著者
関連著者
-
Tashiro Shin-ichi
Dep. Of Clinical And Biomedical Sciences Showa Pharmaceutical Univ. Jpn
-
ONODERA Satoshi
Department of Clinical and Biomedical Sciences, Showa Pharmaceutical University
-
IKEJIMA Takashi
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Unive
-
Wu Li-jun
Department Of Phytochemistry Shenyang Pharmaceutical University
-
Huang Jian
Department Of Phytochemistry Shenyang Pharmaceutical University
-
Wu L
Department Of Phytochemistry Shenyang Pharmaceutical University
-
Onodera S
Dep. Of Clinical And Biomedical Sciences Showa Pharmaceutical Univ. Jpn
-
Onodera Satoshi
昭和薬科大学 病態科
-
Ikejima Takashi
China-japan Res. Inst. Of Medical And Pharmaceutical Sciences Shenyang Pharmaceutical Univ. Chn
-
WU Lijun
Department of Phytochemistry, Shenyang Pharmaceutical University
-
HUANG Jian
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical Unive
-
Tashiro Shin-ichi
Department Of Clinical And Biomedical Sciences Showa Pharmaceutical University
-
Onodera Satoshi
Department Of Cinical And Biomedical Sciences Showa Pharmaceutical University
-
Tashiro Shin-ichi
Department Of Cinical And Biomedical Sciences Showa Pharmaceutical University
-
Tashiro S
Department Of Clinical And Biomedical Sciences Showa Pharmaceutical University
-
Onodera S
Department Of Clinical And Biomedical Sciences Showa Pharmaceutical University
-
Ikejima Takashi
China–Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University
-
TASHIRO Shin-ichi
Department of Clinical and Biomedical Sciences, Showa Pharmaceutical University
-
TASHIRO Shinichi
Department of Clinical and Biomedical Science, Showa Pharmeceutical University
著作論文
- Fibroblast Growth Factor-2 Suppresses Oridonin-Induced L929 Apoptosis Through Extracellular Signal-Regulated Kinase-Dependent and Phosphatidylinositol 3-Kinase-Independent Pathway
- Bcl-2 Up-Regulation and P-p53 Down-Regulation Account for the Low Sensitivity of Murine L929 Fibrosarcoma Cells to Oridonin-Induced Apoptosis(Pharmacology)